Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU MARCHE : revenue, balance sheet and financial ratios

PHARMACIE DU MARCHE is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CHATENOY-LE-ROYAL (71880), this company of category PME shows in 2025 a net income positive of 133 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE DU MARCHE (SIREN 851417626)
Indicador 2025 2024 2023 2022 2021 2020
Ingresos N/C N/C N/C N/C N/C N/C
Resultado neto 132 926 € 116 311 € 121 080 € 180 403 € 125 609 € 82 330 €
EBITDA N/C N/C N/C N/C N/C N/C
Margen neto N/C N/C N/C N/C N/C N/C

Ingresos y cuenta de resultados

In 2025, PHARMACIE DU MARCHE generates positive net income of 133 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 82 k€ -> 133 k€.

Resultado neto (2025) ?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios

132 926 €

Chargement du compte de résultat...

Évolution graphique

Mostrar :

Activo

Chargement des données...

Pasivo

Chargement des données...

Ratios de solvencia y endeudamiento

The debt ratio (= Financial debt / Equity x 100) stands at 85%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Ratio de endeudamiento (2025) ?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible
50-100% : Moderado
> 100% : Alto

85.494%

Autonomía financiera (2025) ?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Fórmula
(Fondos propios / Total balance) x 100
Interpretación
> 30% : Buena autonomía
20-30% : Media
< 20% : Faible

47.356%

Ratio de obsolescencia (2025) ?
Ratio de obsolescencia
Definición
Mide el grado de desgaste del inmovilizado material.
Fórmula
Amortización acumulada / Inmovilizado bruto x 100
Interpretación
< 50% : Activos recientes
50-70% : Desgaste normal
> 70% : Activos envejecidos

31.7%

Evolución de indicadores de solvencia
PHARMACIE DU MARCHE

Positionnement sectoriel

Debt ratio
85.49 2025
2023
2024
2025
Q1: 13.71
Méd: 49.76
Q3: 129.07
Average -14 pts durante 3 años

In 2025, the debt ratio of PHARMACIE DU MARCHE (85.49) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
47.36% 2025
2023
2024
2025
Q1: 33.42%
Méd: 53.71%
Q3: 72.08%
Average +13 pts durante 3 años

In 2025, the financial autonomy of PHARMACIE DU MARCHE (47.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Ratios de liquidez

The liquidity ratio (= Current assets / Current liabilities) stands at 225.12. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Ratio de liquidez (2025) ?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno
1-1.5 : Correcto
< 1 : Risque de liquidité

225.117

Evolución de indicadores de liquidez
PHARMACIE DU MARCHE

Positionnement sectoriel

Liquidity ratio
225.12 2025
2023
2024
2025
Q1: 131.03
Méd: 182.29
Q3: 258.7
Good -11 pts durante 3 años

In 2025, the liquidity ratio of PHARMACIE DU MARCHE (225.12) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positionnement de PHARMACIE DU MARCHE dans son secteur

Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Estimación de valoración

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DU MARCHE is estimated at 2 111 545 € (range 1 432 904€ - 3 313 305€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1432k€ 2111k€ 3313k€
2 111 545 € Range: 1 432 904€ - 3 313 305€
NAF 5 année 2025

Valuation method used

Net Income Multiple
132 926 € × 15.9x = 2 111 545 €
Range: 1 432 905€ - 3 313 305€

Only this financial indicator is available for this company.

Evolución de la valoración

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU MARCHE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU MARCHE

What is the revenue of PHARMACIE DU MARCHE ?

The revenue of PHARMACIE DU MARCHE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DU MARCHE profitable?

Yes, PHARMACIE DU MARCHE generated a net profit of 133 k€ in 2025.

Where is the headquarters of PHARMACIE DU MARCHE ?

The headquarters of PHARMACIE DU MARCHE is located in CHATENOY-LE-ROYAL (71880), in the department Saone-et-Loire.

Where to find the tax return of PHARMACIE DU MARCHE ?

The tax return of PHARMACIE DU MARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU MARCHE operate?

PHARMACIE DU MARCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.